This may serve as a crucial insight for future understanding of how HMGB2 promotes immunosuppression in the local immune microenvironment of HCC, thereby facilitating tumor invasion, metastasis, or resistance to immunotherapy. This evidence concerns the gene HMGB2 and hepatocellular carcinoma.